NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH 
Evotec Receives Milestone Payment For Start Of Second Phase II Trial In Its Multi-Target Alliance With Bayer
PHASE II CLINICAL TRIAL ON PERSISTENT CHRONIC COUGH HAMBURG, GERMANY / ACCESSWIRE / February 28, 2019 / Evotec AG (OTC...
Theralase Named to 2019 TSX Venture 50(TM)
Theralase Achieves Third Place in the Clean Technology and Life Sciences Category on the 2019 TSX Venture 50 TM TORONTO,...
EviTrade Provides Update on Hemp Based Extraction and Processing Facility
VANCOUVER, BC / ACCESSWIRE / February 28, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the ''Company'') provides...
Meet IKU DAO: The Company Prioritizing Drug Discovery By The Consumers
DALLAS, TX / ACCESSWIRE / February 26, 2019 / What if there was a way to prioritize drug discovery by...
MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / February 27, 2019 / MorphoSys AG (FSE: MOR) (NASDAQ: MOR) announced today that...
Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR
Data identifies a simple blood test that predicts clinical response to pelareorep CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE...
Sohm, Inc., Announces Shares Buyback Program
CHINO HILLS, CA / ACCESSWIRE / February 26, 2019 / SOHM, Inc. (OTC PINK: SHMN), a generic Pharmaceutical, Nutraceutical, and...
People Unlimited to Present on Ageless Prosperity
James Strole and Bernadeane of People Unlimited, Inc. have dedicated their lives to building a community for ageless prosperity. This...
Eviana Announces Deal to Sell 155 Metric Tonnes of Industrial Hemp to International Cannabis Corp.
VANCOUVER, BC / ACCESSWIRE / February 25, 2019 / Eviana Health Corporation ("Eviana". the "Company") (CSE: EHC) (OTC: EVNNF) is...
International Cannabrands Announces New Appointments to Board and Management
CALGARY, AB / ACCESSWIRE / February 26, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
Callitas Health Expands Agreement with NFI Consumer Healthcare to Distribute Co-Branded Product
CINCINNATI, OH / ACCESSWIRE / February 26, 2019 / Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the "Company"...
PPJ Healthcare Enterprises, Inc. Announces Retirement of 3,400,000,000 Shares of Common Stock
TAMPA, FL / ACCESSWIRE / February 25, 2019 / PPJ Healthcare Enterprises, Inc. (OTC PINK: PPJE) today announced the retirement...
Strategic Management Opportunity Corporation (SMPP.PK) Announces Acquisition of US Canniceuticals, LLC, Lessor of 20 Acres of Fertile Colorado Land
DENVER, CO / ACCESSWIRE / February 25, 2019 / Strategic Management Opportunity Corporation, a Nevada Corporation trading under the symbol...
Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Thursday, February 28, 2019
SAN FRANCISCO, CA / ACCESSWIRE / February 25, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (''Jaguar'' or the ''Company''), a...
ReShape Vest to be Showcased at 4th Annual Surgical Disruptive Technology Summit
SAN CLEMENTE, CA / ACCESSWIRE / February 25, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
PROTEAMTM(TM) by Hausmann Renews its Platinum Partnership with Professional Football Athletic Trainers Society
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / February 25, 2018 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy,...
Theralase Announces Appointment of New Chief Executive Officers
TORONTO, ON / ACCESSWIRE / February 25, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
Dthera Sciences Announces Exclusivity Period and Option Agreement for its Digital Therapeutic in the Japanese Market
SAN DIEGO, CA / ACCESSWIRE / February 25, 2019 / Dthera™ Sciences (OTCQB: DTHR), a leading digital therapeutic company specialized...
ENDRA Life Sciences to Host Fourth Quarter and Full Year 2018 Results Conference Call on Monday, March 11, 2019 at 4:30 p.m. ET
ANN ARBOR, MICHIGAN / ACCESSWIRE / February 22, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of...
Intellipharmaceutics Announces Fiscal Year 2018 Results
TORONTO, ON / ACCESSWIRE / February 22, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''),...